 | ||||||||
| "anti diabetes" | ||||||||
| WEB | ||||||||
| Lupin, Boehringer Ingelheim to co-market anti-diabetes drug linagliptin in India NEW DELHI: Drug majors Lupin and Boehringer Ingelheim today announced a strategic alliance to co-market anti-diabetes drug linagliptin in India.
| ||||||||
Msd Diabetes Drug On its part, the US drug firm had said its anti-diabetes drug Januvia is not costly at Rs 43 a pill, which … The Delhi High Court on Wednesday ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.